• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在低流行率国家对严重急性呼吸综合征冠状病毒2进行普遍入院前筛查的陷阱。

Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low Prevalence Country.

作者信息

Jung Jiwon, Kim Jinyeong, Lim Joon Seo, Kim Eun Ok, Kim Mi-Na, Kim Sung-Han

机构信息

Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.

Division of Infectious Disease, Department of Internal Medicine, Hanyang University Guri Hospital, Guri 11923, Korea.

出版信息

Viruses. 2021 Apr 30;13(5):804. doi: 10.3390/v13050804.

DOI:10.3390/v13050804
PMID:33946201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8145721/
Abstract

It is unclear whether universal PCR screening for SARS-CoV-2 in asymptomatic individuals prior to admission is useful. From April to December 2020, the positive rate of universal pre-admission screening was 0.005% (4/76,521) in a tertiary care hospital in Korea. The positive rates were not different between the periods (period 1 (daily new patients of <1 per million inhabitants) vs. period 2 (1-8.3 per million inhabitants) vs. period 3 (10.3 to 20 per million inhabitants); = 0.45). Universal pre-admission screening for SARS-CoV-2 had a lower positive rate than that of symptom-based screening (0.005% vs. 0.049% (53/109,257), < 0.001). In addition, seven patients with negative pre-admission test results had subsequent positive PCR during hospitalization, and four patients had secondary transmission. Universal pre-admission PCR screening may not be practical in settings of low prevalence of COVID-19, and negative PCR results at admission should not serve as a basis for underestimating the risk of nosocomial spread from asymptomatic patients.

摘要

入院前对无症状个体进行SARS-CoV-2的普遍PCR筛查是否有用尚不清楚。2020年4月至12月,韩国一家三级护理医院中普遍入院前筛查的阳性率为0.005%(4/76,521)。各时间段之间的阳性率没有差异(第1期(每百万居民中每日新增患者<1例)与第2期(每百万居民中1 - 8.3例)与第3期(每百万居民中10.3至20例);P = 0.45)。SARS-CoV-2的普遍入院前筛查阳性率低于基于症状的筛查(0.005%对0.049%(53/109,257),P < 0.001)。此外,7例入院前检测结果为阴性的患者在住院期间随后PCR检测呈阳性,4例发生了二次传播。在COVID-19患病率较低的情况下,普遍入院前PCR筛查可能不实用,入院时PCR检测阴性结果不应作为低估无症状患者医院内传播风险的依据。

相似文献

1
Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low Prevalence Country.在低流行率国家对严重急性呼吸综合征冠状病毒2进行普遍入院前筛查的陷阱。
Viruses. 2021 Apr 30;13(5):804. doi: 10.3390/v13050804.
2
Universal PCR screening for coronavirus disease 2019 in asymptomatic patients on admission.对入院时无症状的患者进行2019冠状病毒病的通用聚合酶链反应筛查。
Clin Microbiol Infect. 2021 Apr;27(4):658-659. doi: 10.1016/j.cmi.2020.11.010. Epub 2020 Nov 19.
3
Questionnaire-based vs universal PCR testing for SARS-CoV-2 in women admitted for delivery.基于问卷的与通用 PCR 检测在因分娩而住院的女性中用于 SARS-CoV-2 的比较。
Birth. 2021 Mar;48(1):96-103. doi: 10.1111/birt.12520. Epub 2020 Dec 1.
4
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery.在分娩期间对孕妇进行严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的全面筛查。
Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:400-404. doi: 10.1016/j.ejogrb.2020.11.069. Epub 2020 Dec 1.
5
Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers.在资源有限的情况下对 4040 名医护人员进行通用的 COVID-19 筛查:埃及在拥有 12 所公立医院和医疗中心的大学中的试点模式。
Int J Epidemiol. 2021 Mar 3;50(1):50-61. doi: 10.1093/ije/dyaa173.
6
Prolonged SARS-CoV-2 detection and reversed RT-PCR results in mild or asymptomatic patients.在轻症或无症状患者中可长时间检测到 SARS-CoV-2 并出现逆转录聚合酶链反应(RT-PCR)结果转阴。
Infect Dis (Lond). 2021 Jan;53(1):31-37. doi: 10.1080/23744235.2020.1820076. Epub 2020 Sep 16.
7
Universal screening for SARS-CoV-2 infection: a rapid review.SARS-CoV-2 感染的普遍筛查:快速综述。
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
8
Performance and feasibility of universal PCR admission screening for SARS-CoV-2 in a German tertiary care hospital.德国一家三级保健医院中用于 SARS-CoV-2 的通用 PCR 入院筛查的性能和可行性。
J Med Virol. 2021 May;93(5):2890-2898. doi: 10.1002/jmv.26770. Epub 2021 Feb 15.
9
Samba II PCR testing for COVID-19 in pregnant women: a retrospective cohort study and literature review.Samba II PCR 检测在孕妇 COVID-19 中的应用:一项回顾性队列研究和文献综述。
BMC Pregnancy Childbirth. 2021 Mar 17;21(1):212. doi: 10.1186/s12884-021-03653-4.
10
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.

引用本文的文献

1
Coronavirus disease 2019 (COVID-19) universal admission screening in patients and companions in Taiwan from May 2021 to June 2022: A nationwide multicenter study.2021 年 5 月至 2022 年 6 月台湾地区对患者和陪伴者进行 2019 冠状病毒疾病(COVID-19)全面入院筛查:一项全国性多中心研究。
Infect Control Hosp Epidemiol. 2024 Jan;45(1):68-74. doi: 10.1017/ice.2023.144. Epub 2023 Jul 18.
2
Parallel dynamics in the yield of universal SARS-CoV-2 admission screening and population incidence.普遍的 SARS-CoV-2 入院筛查和人群发病率的平行动态。
Sci Rep. 2023 May 5;13(1):7296. doi: 10.1038/s41598-023-33824-6.
3
DNA amplification tests at universal pre-admission screening with enhanced precaution strategies for asymptomatic patients with COVID-19.

本文引用的文献

1
The Proportion of SARS-CoV-2 Infections That Are Asymptomatic.无症状的新型冠状病毒感染比例。
Ann Intern Med. 2021 Sep;174(9):1344-1345. doi: 10.7326/L21-0491.
2
Analysis of Asymptomatic and Presymptomatic Transmission in SARS-CoV-2 Outbreak, Germany, 2020.2020年德国新冠病毒疫情中无症状和症状前传播情况分析
Emerg Infect Dis. 2021 Apr;27(4):1159-63. doi: 10.3201/eid2704.204576. Epub 2021 Feb 18.
3
Frequency of Routine Testing for Coronavirus Disease 2019 (COVID-19) in High-risk Healthcare Environments to Reduce Outbreaks.
在对新冠病毒病无症状患者进行普遍入院前筛查时采用强化预防策略的DNA扩增检测。
IJID Reg. 2023 Jun;7:6-10. doi: 10.1016/j.ijregi.2022.12.010. Epub 2022 Dec 31.
4
Usefulness of universal SARS-CoV-2 PCR testing for inpatients and their caregivers during the omicron era.在奥密克戎时代,针对住院患者及其护理人员进行新冠病毒通用聚合酶链反应检测的效用。
Heliyon. 2022 Oct;8(10):e11008. doi: 10.1016/j.heliyon.2022.e11008. Epub 2022 Oct 10.
5
COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting.住院患者的新冠病毒病筛查:扩大医院监测在低流行环境中的作用
J Multidiscip Healthc. 2021 Oct 27;14:3027-3034. doi: 10.2147/JMDH.S337258. eCollection 2021.
高风险医疗环境中常规检测 2019 年冠状病毒病(COVID-19)以减少疫情爆发的频率。
Clin Infect Dis. 2021 Nov 2;73(9):e3127-e3129. doi: 10.1093/cid/ciaa1383.
4
A SARS-CoV-2 Cluster in an Acute Care Hospital.一起发生在急性护理医院的 SARS-CoV-2 聚集性感染事件。
Ann Intern Med. 2021 Jun;174(6):794-802. doi: 10.7326/M20-7567. Epub 2021 Feb 9.
5
Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study.家庭传播 SARS-CoV-2 及武汉地区易感性和传染性的危险因素:一项回顾性观察研究。
Lancet Infect Dis. 2021 May;21(5):617-628. doi: 10.1016/S1473-3099(20)30981-6. Epub 2021 Jan 18.
6
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms.SARS-CoV-2 从无 COVID-19 症状者传播。
JAMA Netw Open. 2021 Jan 4;4(1):e2035057. doi: 10.1001/jamanetworkopen.2020.35057.
7
Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020.瑞士 2020 年对住院患者进行的 SARS-CoV-2 感染普遍筛查。
Emerg Infect Dis. 2021 Feb;27(2):404-410. doi: 10.3201/eid2702.202318. Epub 2021 Jan 4.
8
Severe Acute Respiratory Syndrome Coronavirus 2 Surveillance and Exposure in the Perioperative Setting With Universal Testing and Personal Protective Equipment Policies.严重急性呼吸综合征冠状病毒 2 监测和围手术期暴露,采用通用测试和个人防护设备政策。
Clin Infect Dis. 2021 Nov 2;73(9):e3013-e3018. doi: 10.1093/cid/ciaa1607.
9
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.无症状和出现症状前 SARS-CoV-2 感染的发生和传播潜力:一项实时系统评价和荟萃分析。
PLoS Med. 2020 Sep 22;17(9):e1003346. doi: 10.1371/journal.pmed.1003346. eCollection 2020 Sep.
10
Pooling Upper Respiratory Specimens for Rapid Mass Screening of COVID-19 by Real-Time RT-PCR.实时 RT-PCR 对呼吸道样本进行快速批量筛查 COVID-19。
Emerg Infect Dis. 2020 Oct;26(10):2469-2472. doi: 10.3201/eid2610.201955. Epub 2020 Aug 26.